UnitedHealth Group (NYSE:UNH) Shares Down 1% - Time to Sell?

Key Points

• UnitedHealth shares fell 1% to about $406.67, though the stock remains above its 50-day and 200-day moving averages.
• The company recently beat quarterly earnings and revenue expectations and raised its full-year outlook, while Morgan Stanley cited recovering margins and raised its price target. However, elevated medical costs, commercial insurance, Medicaid, and AI spending remain execution risks.
• Analysts maintain a generally positive view, with a “Moderate Buy” consensus and an average price target of $463.93. UnitedHealth also offers a $9.28 annualized dividend, yielding approximately 2.3%, but Zacks cautioned about near-term earnings pressure.

UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) shares dropped 1% on Friday. The stock traded as low as $405.91 and last traded at $406.67. Approximately 4,292,451 shares traded hands during mid-day trading, a decline of 41% from the average session volume of 7,261,615 shares. The stock had previously closed at $410.91.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Improving margins and higher price target: Morgan Stanley said UnitedHealth’s margins are recovering, with Medicare operations returning to a more normal range, and raised its price target. However, commercial insurance, Medicaid and increased AI-related spending remain important execution tests. UnitedHealth is bouncing back, but a major risk remains
• Positive Sentiment: Recent earnings beat and raised guidance: UnitedHealth’s latest quarterly results exceeded expectations for both earnings and revenue, and the company raised its outlook. The earnings recovery supports the case that operating performance is stabilizing after earlier pressure. Why Did UnitedHealth Raise Guidance After Its Quarterly Beat?
• Positive Sentiment: Dividend appeal: UnitedHealth is highlighted as a major healthcare dividend payer, potentially supporting demand from income-focused investors. The article also cautions that dividend safety should be assessed alongside payout sustainability and business risks. $250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends
• Neutral Sentiment: Analyst estimates are mixed: Zacks Research maintained a “Hold” rating and projects roughly $20.54 in FY2026 EPS, close to the broader consensus near $20.62. It raised several longer-term quarterly estimates but lowered others, including Q1 2027, Q1 2028 and Q2 2028.
• Negative Sentiment: Near-term earnings pressure: Zacks Research issued a negative estimate for fourth-quarter earnings, adding to concerns that high medical utilization and costs could limit profitability despite the Medicare recovery. Zacks Research Has Negative Estimate for UNH Q4 Earnings

Analysts Set New Price Targets

UNH has been the subject of a number of recent research reports. Evercore boosted their price objective on shares of UnitedHealth Group from $400.00 to $480.00 and gave the company an "outperform" rating in a research report on Tuesday, July 7th. Stephens set a $500.00 target price on UnitedHealth Group in a research report on Friday, October 16th. Piper Sandler boosted their price target on UnitedHealth Group from $502.00 to $504.00 and gave the company an "overweight" rating in a report on Wednesday, October 14th. Morgan Stanley upped their price target on UnitedHealth Group from $529.00 to $531.00 and gave the stock an "overweight" rating in a research report on Tuesday. Finally, Wells Fargo & Company decreased their price objective on UnitedHealth Group from $526.00 to $487.00 and set an "overweight" rating on the stock in a research note on Tuesday. Twenty analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $463.93.

UnitedHealth Group Trading Down 1.0%

The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The stock has a fifty day simple moving average of $389.76 and a 200 day simple moving average of $362.07. The firm has a market capitalization of $365.02 billion, a P/E ratio of 23.23, a PEG ratio of 1.47 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating the consensus estimate of $4.14 by $0.55. The business had revenue of $112.70 billion for the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business's revenue was down .4% on a year-over-year basis. During the same period in the previous year, the business earned $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were paid a $2.32 dividend. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group's payout ratio is presently 53.00%.

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.19% of the stock is owned by company insiders.

Institutional Investors Weigh In On UnitedHealth Group

A number of hedge funds have recently bought and sold shares of UNH. City State Bank raised its holdings in shares of UnitedHealth Group by 5.6% in the third quarter. City State Bank now owns 471 shares of the healthcare conglomerate's stock worth $173,000 after buying an additional 25 shares during the last quarter. Murphy Pohlad Asset Management LLC lifted its stake in shares of UnitedHealth Group by 0.5% during the third quarter. Murphy Pohlad Asset Management LLC now owns 5,305 shares of the healthcare conglomerate's stock worth $1,947,000 after buying an additional 25 shares during the period. Synergy Financial Group LTD grew its holdings in shares of UnitedHealth Group by 3.1% during the second quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate's stock valued at $369,000 after buying an additional 27 shares during the last quarter. LFG Wealth Partners LLC increased its position in shares of UnitedHealth Group by 3.3% in the 2nd quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate's stock valued at $355,000 after acquiring an additional 27 shares during the period. Finally, Ares Financial Consulting LLC increased its position in shares of UnitedHealth Group by 7.2% in the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate's stock valued at $174,000 after acquiring an additional 28 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.